A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: A prospective observational cohort study

Mark J. Siedner, Data Santorino, Alexander J. Lankowski, Michael Kanyesigye, Mwebesa B. Bwana, Jessica E. Haberer, David Bangsberg

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Up to 50 % of HIV-infected persons in sub-Saharan Africa are lost from care between HIV diagnosis and antiretroviral therapy (ART) initiation. Structural barriers, including cost of transportation to clinic and poor communication systems, are major contributors. Methods: We conducted a prospective, pragmatic, before-and-after clinical trial to evaluate a combination mobile health and transportation reimbursement intervention to improve care at a publicly operated HIV clinic in Uganda. Patients undergoing CD4 count testing were enrolled, and clinicians selected a result threshold that would prompt early return for ART initiation or further care. Participants enrolled in the pre-intervention period (January - August 2012) served as a control group. Participants in the intervention period (September 2012 - November 2013) were randomized to receive daily short message service (SMS) messages for up to seven days in one of three formats: 1) messages reporting an abnormal result directly, 2) personal identification number-protected messages reporting an abnormal result, or 3) messages reading "ABCDEFG" to confidentially convey an abnormal result. Participants returning within seven days of their first message received transportation reimbursements (about $6USD). Our primary outcomes of interest were time to return to clinic and time to ART initiation. Results: There were 45 participants in the pre-intervention period and 138 participants in the intervention period (46, 49, and 43 in the direct, PIN, and coded groups, respectively) with low CD4 count results. Median time to clinic return was 33 days (IQR 11-49) in the pre-intervention period and 6 days (IQR 3-16) in the intervention period (P < 0.001); and median time to ART initiation was 47 days (IQR 11-75) versus 12 days (IQR 5-19), (P < 0.001). In multivariable models, participants in the intervention period had earlier return to clinic (AHR 2.32, 95 %CI 1.53 to 3.51) and earlier time to ART initiation (AHR 2.27, 95 %CI 1.38 to 3.72). All three randomized message formats improved time to return to clinic and time to ART initiation (P < 0.01 for all comparisons versus the pre-intervention period). Conclusions: A combination of an SMS laboratory result communication system and transportation reimbursements significantly decreased time to clinic return and time to ART initiation after abnormal CD4 test results. Trial registrations: Clinicaltrials.gov NCT01579214 , approved 13 April 2012.

Original languageEnglish (US)
Article number160
JournalBMC Medicine
Volume13
Issue number1
DOIs
StatePublished - Jul 6 2015
Externally publishedYes

Fingerprint

Text Messaging
Uganda
Observational Studies
Cohort Studies
HIV
CD4 Lymphocyte Count
Therapeutics
Telemedicine
Africa South of the Sahara
Reading
Communication
Clinical Trials
Costs and Cost Analysis

Keywords

  • Antiretroviral therapy
  • Clinical trial
  • Financial incentive
  • HIV/AIDS
  • Short message service
  • Sub-Saharan Africa

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda : A prospective observational cohort study. / Siedner, Mark J.; Santorino, Data; Lankowski, Alexander J.; Kanyesigye, Michael; Bwana, Mwebesa B.; Haberer, Jessica E.; Bangsberg, David.

In: BMC Medicine, Vol. 13, No. 1, 160, 06.07.2015.

Research output: Contribution to journalArticle

Siedner, Mark J. ; Santorino, Data ; Lankowski, Alexander J. ; Kanyesigye, Michael ; Bwana, Mwebesa B. ; Haberer, Jessica E. ; Bangsberg, David. / A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda : A prospective observational cohort study. In: BMC Medicine. 2015 ; Vol. 13, No. 1.
@article{ab6e947e919545548b17775bc924835e,
title = "A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: A prospective observational cohort study",
abstract = "Background: Up to 50 {\%} of HIV-infected persons in sub-Saharan Africa are lost from care between HIV diagnosis and antiretroviral therapy (ART) initiation. Structural barriers, including cost of transportation to clinic and poor communication systems, are major contributors. Methods: We conducted a prospective, pragmatic, before-and-after clinical trial to evaluate a combination mobile health and transportation reimbursement intervention to improve care at a publicly operated HIV clinic in Uganda. Patients undergoing CD4 count testing were enrolled, and clinicians selected a result threshold that would prompt early return for ART initiation or further care. Participants enrolled in the pre-intervention period (January - August 2012) served as a control group. Participants in the intervention period (September 2012 - November 2013) were randomized to receive daily short message service (SMS) messages for up to seven days in one of three formats: 1) messages reporting an abnormal result directly, 2) personal identification number-protected messages reporting an abnormal result, or 3) messages reading {"}ABCDEFG{"} to confidentially convey an abnormal result. Participants returning within seven days of their first message received transportation reimbursements (about $6USD). Our primary outcomes of interest were time to return to clinic and time to ART initiation. Results: There were 45 participants in the pre-intervention period and 138 participants in the intervention period (46, 49, and 43 in the direct, PIN, and coded groups, respectively) with low CD4 count results. Median time to clinic return was 33 days (IQR 11-49) in the pre-intervention period and 6 days (IQR 3-16) in the intervention period (P < 0.001); and median time to ART initiation was 47 days (IQR 11-75) versus 12 days (IQR 5-19), (P < 0.001). In multivariable models, participants in the intervention period had earlier return to clinic (AHR 2.32, 95 {\%}CI 1.53 to 3.51) and earlier time to ART initiation (AHR 2.27, 95 {\%}CI 1.38 to 3.72). All three randomized message formats improved time to return to clinic and time to ART initiation (P < 0.01 for all comparisons versus the pre-intervention period). Conclusions: A combination of an SMS laboratory result communication system and transportation reimbursements significantly decreased time to clinic return and time to ART initiation after abnormal CD4 test results. Trial registrations: Clinicaltrials.gov NCT01579214 , approved 13 April 2012.",
keywords = "Antiretroviral therapy, Clinical trial, Financial incentive, HIV/AIDS, Short message service, Sub-Saharan Africa",
author = "Siedner, {Mark J.} and Data Santorino and Lankowski, {Alexander J.} and Michael Kanyesigye and Bwana, {Mwebesa B.} and Haberer, {Jessica E.} and David Bangsberg",
year = "2015",
month = "7",
day = "6",
doi = "10.1186/s12916-015-0397-1",
language = "English (US)",
volume = "13",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda

T2 - A prospective observational cohort study

AU - Siedner, Mark J.

AU - Santorino, Data

AU - Lankowski, Alexander J.

AU - Kanyesigye, Michael

AU - Bwana, Mwebesa B.

AU - Haberer, Jessica E.

AU - Bangsberg, David

PY - 2015/7/6

Y1 - 2015/7/6

N2 - Background: Up to 50 % of HIV-infected persons in sub-Saharan Africa are lost from care between HIV diagnosis and antiretroviral therapy (ART) initiation. Structural barriers, including cost of transportation to clinic and poor communication systems, are major contributors. Methods: We conducted a prospective, pragmatic, before-and-after clinical trial to evaluate a combination mobile health and transportation reimbursement intervention to improve care at a publicly operated HIV clinic in Uganda. Patients undergoing CD4 count testing were enrolled, and clinicians selected a result threshold that would prompt early return for ART initiation or further care. Participants enrolled in the pre-intervention period (January - August 2012) served as a control group. Participants in the intervention period (September 2012 - November 2013) were randomized to receive daily short message service (SMS) messages for up to seven days in one of three formats: 1) messages reporting an abnormal result directly, 2) personal identification number-protected messages reporting an abnormal result, or 3) messages reading "ABCDEFG" to confidentially convey an abnormal result. Participants returning within seven days of their first message received transportation reimbursements (about $6USD). Our primary outcomes of interest were time to return to clinic and time to ART initiation. Results: There were 45 participants in the pre-intervention period and 138 participants in the intervention period (46, 49, and 43 in the direct, PIN, and coded groups, respectively) with low CD4 count results. Median time to clinic return was 33 days (IQR 11-49) in the pre-intervention period and 6 days (IQR 3-16) in the intervention period (P < 0.001); and median time to ART initiation was 47 days (IQR 11-75) versus 12 days (IQR 5-19), (P < 0.001). In multivariable models, participants in the intervention period had earlier return to clinic (AHR 2.32, 95 %CI 1.53 to 3.51) and earlier time to ART initiation (AHR 2.27, 95 %CI 1.38 to 3.72). All three randomized message formats improved time to return to clinic and time to ART initiation (P < 0.01 for all comparisons versus the pre-intervention period). Conclusions: A combination of an SMS laboratory result communication system and transportation reimbursements significantly decreased time to clinic return and time to ART initiation after abnormal CD4 test results. Trial registrations: Clinicaltrials.gov NCT01579214 , approved 13 April 2012.

AB - Background: Up to 50 % of HIV-infected persons in sub-Saharan Africa are lost from care between HIV diagnosis and antiretroviral therapy (ART) initiation. Structural barriers, including cost of transportation to clinic and poor communication systems, are major contributors. Methods: We conducted a prospective, pragmatic, before-and-after clinical trial to evaluate a combination mobile health and transportation reimbursement intervention to improve care at a publicly operated HIV clinic in Uganda. Patients undergoing CD4 count testing were enrolled, and clinicians selected a result threshold that would prompt early return for ART initiation or further care. Participants enrolled in the pre-intervention period (January - August 2012) served as a control group. Participants in the intervention period (September 2012 - November 2013) were randomized to receive daily short message service (SMS) messages for up to seven days in one of three formats: 1) messages reporting an abnormal result directly, 2) personal identification number-protected messages reporting an abnormal result, or 3) messages reading "ABCDEFG" to confidentially convey an abnormal result. Participants returning within seven days of their first message received transportation reimbursements (about $6USD). Our primary outcomes of interest were time to return to clinic and time to ART initiation. Results: There were 45 participants in the pre-intervention period and 138 participants in the intervention period (46, 49, and 43 in the direct, PIN, and coded groups, respectively) with low CD4 count results. Median time to clinic return was 33 days (IQR 11-49) in the pre-intervention period and 6 days (IQR 3-16) in the intervention period (P < 0.001); and median time to ART initiation was 47 days (IQR 11-75) versus 12 days (IQR 5-19), (P < 0.001). In multivariable models, participants in the intervention period had earlier return to clinic (AHR 2.32, 95 %CI 1.53 to 3.51) and earlier time to ART initiation (AHR 2.27, 95 %CI 1.38 to 3.72). All three randomized message formats improved time to return to clinic and time to ART initiation (P < 0.01 for all comparisons versus the pre-intervention period). Conclusions: A combination of an SMS laboratory result communication system and transportation reimbursements significantly decreased time to clinic return and time to ART initiation after abnormal CD4 test results. Trial registrations: Clinicaltrials.gov NCT01579214 , approved 13 April 2012.

KW - Antiretroviral therapy

KW - Clinical trial

KW - Financial incentive

KW - HIV/AIDS

KW - Short message service

KW - Sub-Saharan Africa

UR - http://www.scopus.com/inward/record.url?scp=84935473048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935473048&partnerID=8YFLogxK

U2 - 10.1186/s12916-015-0397-1

DO - 10.1186/s12916-015-0397-1

M3 - Article

C2 - 26149722

AN - SCOPUS:84935473048

VL - 13

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

IS - 1

M1 - 160

ER -